Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 48NIH 4OTHER_GOV 3NETWORK 2INDUSTRY 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 2Breast 2

Conditions

Ovarian Neoplasms 117Uterine Cervical Neoplasms 65Carcinoma, Ovarian Epithelial 64Fallopian Tube Neoplasms 62Endometrial Neoplasms 38Brenner Tumor 22Sarcoma 18Testicular Neoplasms 15Vulvar Neoplasms 12Squamous Intraepithelial Lesions 10Sarcoma, Endometrial Stromal 10Endometrial Adenocarcinoma 10Breast Neoplasms 10Ovarian Germ Cell Cancer 9HIV Infections 9Teratoma 7Sarcoma, Synovial 7Precancerous Conditions 7Osteosarcoma 7Neurofibrosarcoma 7Neuroblastoma 7Melanoma 7Liposarcoma 7Leiomyosarcoma 7Histiocytoma, Malignant Fibrous 7Hemangiosarcoma 7Fibrosarcoma 7Carcinoma, Non-Small-Cell Lung 7Uterine Cervical Dysplasia 6Stomach Neoplasms 6

Interventions

Zoledronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Hereditary Breast and Ovarian Cancer Syndrome × Gynecologic × Clear all
NCT01445275 2024-08-21

Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199

GOG Foundation

Withdrawn
BreastGynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

NCT00305695 2020-03-24

Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries

GOG Foundation

Phase 2 Completed
160 enrolled 10 charts
BreastGynecologic

Osteoporosis, Ovarian Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡